➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Colorcon
McKesson
McKinsey
Merck

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

BAXTER HLTHCARE CORP Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?

BAXTER HLTHCARE CORP has fifty approved drugs.

There are twelve US patents protecting BAXTER HLTHCARE CORP drugs. There are two tentative approvals on BAXTER HLTHCARE CORP drugs.

There is one patent family member on BAXTER HLTHCARE CORP drugs in one country and eighty-nine supplementary protection certificates in fourteen countries.

Summary for BAXTER HLTHCARE CORP
International Patents:1
US Patents:12
Tradenames:62
Ingredients:38
NDAs:50

Drugs and US Patents for BAXTER HLTHCARE CORP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 11,045,438 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Baxter Hlthcare Corp PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-013 Oct 10, 2008 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare Corp PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate INJECTABLE;INJECTION 207026-001 Jan 13, 2015 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare Corp NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214313-001 Jan 15, 2021 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare Corp BUTORPHANOL TARTRATE PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 075695-001 Oct 23, 2001 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 10,543,186 ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare Corp EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 208554-001 Nov 23, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BAXTER HLTHCARE CORP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 5,213,804 ⤷  Free Forever Trial
Baxter Hlthcare Corp CLINOLIPID 20% olive oil; soybean oil EMULSION;INTRAVENOUS 204508-001 Oct 3, 2013 5,840,757 ⤷  Free Forever Trial
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,262,003 ⤷  Free Forever Trial
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,436,741 ⤷  Free Forever Trial
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 5,213,804 ⤷  Free Forever Trial
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 5,013,556 ⤷  Free Forever Trial
Baxter Hlthcare Corp PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018799-001 Dec 13, 1982 3,629,425 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for BAXTER HLTHCARE CORP Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0984957 122012000017 Germany ⤷  Free Forever Trial PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
0984957 CR 2012 00035 Denmark ⤷  Free Forever Trial PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
1429780 132013902137451 Italy ⤷  Free Forever Trial PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106
0206283 SPC/GB97/085 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606
2957286 CR 2018 00043 Denmark ⤷  Free Forever Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721
1685839 92292 Luxembourg ⤷  Free Forever Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
2957286 C02957286/01 Switzerland ⤷  Free Forever Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66411 22.12.2017
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Boehringer Ingelheim
Harvard Business School
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.